Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy?
- 30 September 2001
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (3) , 432-433
- https://doi.org/10.1016/s0168-8278(01)00107-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activationJournal of Hepatology, 2001
- Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis CAmerican Journal of Gastroenterology, 2000
- Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3Journal of Hepatology, 2000
- Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patientsLiver International, 1999
- Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and SteatosisHepatology, 1999
- Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammationJournal of Hepatology, 1998
- Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.Journal of General Virology, 1997
- Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosisHepatology, 1995